These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 20823402)

  • 1. NF-kappaB: much learned, much to learn.
    Razani B; Cheng G
    Sci Signal; 2010 Sep; 3(138):pe29. PubMed ID: 20823402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomics and NF-κB: an update.
    Niederberger E; Geisslinger G
    Expert Rev Proteomics; 2013 Apr; 10(2):189-204. PubMed ID: 23573785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NF-kappaB and the immune response.
    Hayden MS; West AP; Ghosh S
    Oncogene; 2006 Oct; 25(51):6758-80. PubMed ID: 17072327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-canonical NF-κB signaling activation and regulation: principles and perspectives.
    Razani B; Reichardt AD; Cheng G
    Immunol Rev; 2011 Nov; 244(1):44-54. PubMed ID: 22017430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclear factor-kappaB: its role in health and disease.
    Kumar A; Takada Y; Boriek AM; Aggarwal BB
    J Mol Med (Berl); 2004 Jul; 82(7):434-48. PubMed ID: 15175863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contradictory functions of NF-kappaB in liver physiology and cancer.
    Vainer GW; Pikarsky E; Ben-Neriah Y
    Cancer Lett; 2008 Aug; 267(2):182-8. PubMed ID: 18479806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lessons learned from molecular defects in nuclear factor kappaB dependent signaling.
    McDonald DR; Janssen R; Geha R
    Microbes Infect; 2006 Apr; 8(4):1151-6. PubMed ID: 16517203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circuitry of nuclear factor kappaB signaling.
    Hoffmann A; Baltimore D
    Immunol Rev; 2006 Apr; 210():171-86. PubMed ID: 16623771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuclear transcription factor NF-kappa B: role in biology and medicine.
    Aggarwal BB; Takada Y; Shishodia S; Gutierrez AM; Oommen OV; Ichikawa H; Baba Y; Kumar A
    Indian J Exp Biol; 2004 Apr; 42(4):341-53. PubMed ID: 15088683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The non-canonical NF-κB pathway in immunity and inflammation.
    Sun SC
    Nat Rev Immunol; 2017 Sep; 17(9):545-558. PubMed ID: 28580957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antagonistic crosstalk between NF-κB and SIRT1 in the regulation of inflammation and metabolic disorders.
    Kauppinen A; Suuronen T; Ojala J; Kaarniranta K; Salminen A
    Cell Signal; 2013 Oct; 25(10):1939-48. PubMed ID: 23770291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune deficiency or hyperactivity-Nf-kappab illuminates autoimmunity.
    Pai S; Thomas R
    J Autoimmun; 2008 Nov; 31(3):245-51. PubMed ID: 18539434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Nuclear Factor κB pathway: A link to the immune system in the radiation response.
    Hellweg CE
    Cancer Lett; 2015 Nov; 368(2):275-89. PubMed ID: 25688671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NF-kappaB and its regulation on the immune system.
    Liang Y; Zhou Y; Shen P
    Cell Mol Immunol; 2004 Oct; 1(5):343-50. PubMed ID: 16285893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SIRT1 longevity factor suppresses NF-kappaB -driven immune responses: regulation of aging via NF-kappaB acetylation?
    Salminen A; Kauppinen A; Suuronen T; Kaarniranta K
    Bioessays; 2008 Oct; 30(10):939-42. PubMed ID: 18800364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NF-κB Signaling in Macrophages: Dynamics, Crosstalk, and Signal Integration.
    Dorrington MG; Fraser IDC
    Front Immunol; 2019; 10():705. PubMed ID: 31024544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NF-kappaB signaling: pros and cons of altering NF-kappaB as a therapeutic approach.
    Egan LJ; Toruner M
    Ann N Y Acad Sci; 2006 Aug; 1072():114-22. PubMed ID: 17057194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB): a new potential therapeutic target in atherosclerosis?
    Dąbek J; Kułach A; Gąsior Z
    Pharmacol Rep; 2010; 62(5):778-83. PubMed ID: 21098861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Control of NF-kappaB activation by the COP9 signalosome.
    Schweitzer K; Naumann M
    Biochem Soc Trans; 2010 Feb; 38(Pt 1):156-61. PubMed ID: 20074051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation and function of IKK and IKK-related kinases.
    Häcker H; Karin M
    Sci STKE; 2006 Oct; 2006(357):re13. PubMed ID: 17047224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.